Zdrowie i gospodarka · 20/04/2016
FDA Releases Revised Draft Guidance on Comparability Protocols for Human Drugs and Biologics
The Food and Drug Administration (FDA) has made available a revised draft guidance for industry on comparability protocols for human drugs and biologics, aiming to promote the quality manufacturing of pharmaceutical products.
Source: Federal Register — Food and Drug AdministrationOpen original release →